Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.

Zeuzem S, Foster GR, Wang S, Asatryan A, Gane E, Feld JJ, Asselah T, Bourlière M, Ruane PJ, Wedemeyer H, Pol S, Flisiak R, Poordad F, Chuang WL, Stedman CA, Flamm S, Kwo P, Dore GJ, Sepulveda-Arzola G, Roberts SK, Soto-Malave R, Kaita K, Puoti M, Vierling J, Tam E, Vargas HE, Bruck R, Fuster F, Paik SW, Felizarta F, Kort J, Fu B, Liu R, Ng TI, Pilot-Matias T, Lin CW, Trinh R, Mensa FJ

Open source

DOI: 10.1056/nejmoa1702417
Published: 2018 Jan 25
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1702417,
  title = {Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.},
  author = {Zeuzem S and Foster GR and Wang S and Asatryan A and Gane E and Feld JJ and Asselah T and Bourlière M and Ruane PJ and Wedemeyer H and Pol S and Flisiak R and Poordad F and Chuang WL and Stedman CA and Flamm S and Kwo P and Dore GJ and Sepulveda-Arzola G and Roberts SK and Soto-Malave R and Kaita K and Puoti M and Vierling J and Tam E and Vargas HE and Bruck R and Fuster F and Paik SW and Felizarta F and Kort J and Fu B and Liu R and Ng TI and Pilot-Matias T and Lin CW and Trinh R and Mensa FJ},
  year = {2018},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa1702417},
  url = {https://doi.org/10.1056/nejmoa1702417}
}

RIS

TY  - JOUR
TI  - Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.
AU  - Zeuzem S
AU  - Foster GR
AU  - Wang S
AU  - Asatryan A
AU  - Gane E
AU  - Feld JJ
AU  - Asselah T
AU  - Bourlière M
AU  - Ruane PJ
AU  - Wedemeyer H
AU  - Pol S
AU  - Flisiak R
AU  - Poordad F
AU  - Chuang WL
AU  - Stedman CA
AU  - Flamm S
AU  - Kwo P
AU  - Dore GJ
AU  - Sepulveda-Arzola G
AU  - Roberts SK
AU  - Soto-Malave R
AU  - Kaita K
AU  - Puoti M
AU  - Vierling J
AU  - Tam E
AU  - Vargas HE
AU  - Bruck R
AU  - Fuster F
AU  - Paik SW
AU  - Felizarta F
AU  - Kort J
AU  - Fu B
AU  - Liu R
AU  - Ng TI
AU  - Pilot-Matias T
AU  - Lin CW
AU  - Trinh R
AU  - Mensa FJ
PY  - 2018
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa1702417
UR  - https://doi.org/10.1056/nejmoa1702417
ER  -

APA

S, Z., GR, F., S, W., A, A., E, G., JJ, F., T, A., M, B., PJ, R., H, W., S, P., R, F., F, P., WL, C., CA, S., S, F., P, K., GJ, D., G, S., SK, R., R, S., K, K., M, P., J, V., E, T., HE, V., R, B., F, F., SW, P., F, F., J, K., B, F., R, L., TI, N., T, P., CW, L., R, T., & FJ, M. (2018). Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.. The New England journal of medicine. https://doi.org/10.1056/nejmoa1702417

Source records

pubmed · retrieved 2026-09-25T21:36:59.499Z